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Bacterial traits that contribute to disease are termed “virulence factors” and there is much
interest in therapeutic approaches that disrupt such traits. What remains less clear is
whether a virulence factor identified as such in a particular context is also important in
infections involving different host and pathogen types. Here, we address this question
using a meta-analytic approach. We statistically analyzed the infection outcomes of
81 experiments associated with one well-studied virulence factor—pyoverdine, an
iron-scavenging compound secreted by the opportunistic pathogen Pseudomonas
aeruginosa. We found that this factor is consistently involved with virulence across
different infection contexts. However, the magnitude of the effect of pyoverdine on
virulence varied considerably. Moreover, its effect on virulence was relatively minor in
many cases, suggesting that pyoverdine is not indispensable in infections. Our works
supports theoretical models from ecology predicting that disease severity is multifactorial
and context dependent, a fact that might complicate our efforts to identify the most
important virulence factors. More generally, our study highlights how comparative
approaches can be used to quantify the magnitude and general importance of virulence
factors, key knowledge informing future anti-virulence treatment strategies.
Keywords: virulence factor, siderophore, pyoverdine, meta-analysis, virulence
INTRODUCTION
Understanding which bacterial characteristics contribute most to disease is a major area of research
inmicrobiology and infection biology (Rahme et al., 1995; Jimenez et al., 2012; Lebeaux et al., 2014).
Bacterial characteristics that reduce host health and/or survival are considered “virulence factors.”
Such factors include structural features like flagella and pili that facilitate attachment to host cells
(Josenhans and Suerbaum, 2002; Kazmierczak et al., 2015), as well as secreted products like toxins
and enzymes that degrade host tissue (Vasil et al., 1986; Lebrun et al., 2009), or siderophores that
scavenge iron from the host (Miethke and Marahiel, 2007). Research on virulence factors has
not only increased our fundamental understanding of the mechanisms underlying virulence, but
has also identified potential novel targets for antibacterial therapy. There is indeed much current
interest in developing “anti-virulence” drugs to disrupt virulence factor production—the idea being
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that by simply disarming pathogens rather than killing them
outright, we could ostensibly elicit weaker selection for drug
resistance (Clatworthy et al., 2007; Pepper, 2008; Rasko and
Sperandio, 2010).
Although our understanding of different types of virulence
factors and their interactions is continuously deepening, it is still
unclear just how generalizable this assembled knowledge is. It is
often assumed, for reasons of parsimony, that a given structure or
secreted molecule central to the virulence of a particular bacterial
strain in a specific host context will similarly enhance virulence
in another bacterial strain, or in a different host (Dubern
et al., 2015). Yet, ecological theory predicts that the effects of a
given trait will frequently vary in response to the environment
(Lambrechts et al., 2006). In the context of infections, this may
be particularly true for opportunistic pathogens, which face very
heterogeneous environments: they can live in environmental
reservoirs (e.g., soil, household surfaces), as commensals of
healthy hosts, or, when circumstances allow, as pathogens,
causing serious infections in a range of different hosts and host
tissues (Kurz et al., 2003; He et al., 2004; Calderone and Fonzi,
2001). Opportunistic pathogens underlie many hospital-acquired
infections, especially in immune-compromised patients (Gaynes
and Edwards, 2005; Obritsch et al., 2005; Länger and Kreipe,
2011), and the treatment of such infections is often challenging
because, as generalists, such pathogens are pre-selected to be
tenacious and highly adaptable. Thus, in designing new anti-
virulence drugs against opportunistic pathogens, we need to
know not only whether the targeted trait is indeed associated
with pathogenicity, but also the generality of this association
across different pathogen strain backgrounds, host species, and
infection types.
To address this issue, we introduce a meta-analysis approach,
which allows us to quantify variation and overall effects of
virulence factors across host environments. As a test case, we
focus on pyoverdine, a siderophore secreted by the opportunistic
pathogen Pseudomonas aeruginosa to scavenge iron from the host
environment (Visca et al., 2007). Table 1 provides an overview
of the workflow of our meta-analysis, where we combined the
outcomes of 81 individual virulence experiments from 24 studies
(Meyer et al., 1996; Takase et al., 2000; Xiong et al., 2000;
Gallagher and Manoil, 2001; Ochsner et al., 2002; Silo-Suh et al.,
2002; Salunkhe et al., 2005; Harrison et al., 2006; Attila et al., 2008;
Papaioannou et al., 2009; Zaborin et al., 2009; Carter et al., 2010;
Nadal Jimenez et al., 2010; Oliver, 2011; Romanowski et al., 2011;
Feinbaum et al., 2012; Okuda et al., 2012; Imperi et al., 2013;
Kirienko et al., 2013; Ross-Gillespie et al., 2014; Dubern et al.,
2015; Lin et al., 2015; Lopez-Medina et al., 2015; Minandri et al.,
2016, see also Tables S1, S2 in the Supplemental Material). Using
a weighted meta-analysis approach, we were able to investigate
the evidence for pyoverdine’s contribution to virulence across
eight host species, including vertebrates, invertebrates and plants,
five tissue infection models and various P. aeruginosa genotypes.
We chose pyoverdine production as the model trait for our
analysis because: (i) it has been extensively studied across a range
of Pseudomonas strains (Meyer et al., 1997); (ii) its virulence
effects have been examined in a large number of host species;
(iii) P. aeruginosa is one of the most troublesome opportunistic
human pathogens, responsible for many multi-drug resistant
nosocomial infections (Hauser and Rello, 2003; Hirsch and
Tam, 2011); and (iv) multiple anti-virulence drugs have been
proposed to target pyoverdine production and uptake (Kaneko
et al., 2007; Imperi et al., 2013; Ross-Gillespie et al., 2014). The
applied question here, then, is whether targeting pyoverdine
could generally and effectively curb pathogenicity.
MATERIALS AND METHODS
Literature Search
We conducted an extensive literature search, using a combination
of two online databases: Web of Science and Google Scholar.
The following terms were used to search abstracts and full texts:
“aeruginosa” in combination with “pyoverdin” or “pyoverdine”
and in combination with “virulence” or “infection” or “pathogen”
or “disease” or “mortality” or “lethality.” This search was first
performed on May 19th 2014 and it was repeated periodically
until Aug 1st 2016 in order to include more recent publications.
In addition, the reference lists of all shortlisted studies were
scanned for relevant publications. We further contacted the
corresponding authors of several publications to ask for
unpublished datasets. Ultimately, no unpublished datasets were
included in the final meta-analysis (see Supplementary Tables
S1+S3 for details).
Inclusion Criteria
The database search yielded a total of 529 studies, and we
identified 10 additional records through other sources. These
539 studies were then scanned for relevant content according to
the following set of inclusion criteria. Studies were considered
potentially eligible for inclusion if they contained original
research, were written in English and provided data that
compared the virulence of a wildtype pyoverdine-producing
P. aeruginosa strain with that of a mutant strain demonstrating
impaired pyoverdine production. We defined virulence as a
decrease in host fitness, measured as an increase in mortality or
tissue damage when infected with bacteria. We defined “wildtype
strains” as strains that were originally clinical isolates, have
been widely used in laboratories as virulent reference strains
and have not been genetically modified. Strains with impaired
pyoverdine production included strains that were completely
deficient in pyoverdine production and strains that were only
partially deficient, i.e., that produced less than the wildtype strain
under identical experimental conditions. We considered both
genetically engineered knock-out strains and clinical isolates with
reduced pyoverdine production. Since pyoverdine is not directly
encoded in the genome but is synthesized via non-ribosomal
peptide synthesis (Visca et al., 2007), there are no studies
that modified the functioning of pyoverdine through targeted
mutagenesis. There were 32 original publications containing 120
experiments that satisfied our criteria and were thus considered
appropriate for in-depth examination.
We screened these 120 experiments using a second set of
rules to identify those experiments that contain comparable
quantitative data, which is essential for a meta-analysis. Inclusion
criteria were: (i) virulence was measured directly (and not
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TABLE 1 | Meta-analysis workflow for this study.
In general This study Details
1. Formulate hypothesis and predictions HYPOTHESIS: Pyoverdine is an important virulence factor for Pseudomonas
aeruginosa.
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PREDICTION: Pyoverdine-defective mutants cause less virulence than
wildtype strains.
2. Systematically search for relevant studies We searched (see details in main text) for any reports of experiments featuring
monoclonal infections of whole live host organisms with P. aeruginosa strains
known to vary in pyoverdine phenotype, where virulence was quantified in
terms of host mortality.
3. Extract and standardize effect sizes and their standard
errors
For each case reporting host survival, we calculated the (Iog) ratio of mortality
odds from pyoverdine-mutant infections vs. wildtype infections—i.e., the (log)
odds-ratio.
4a. Check heterogeneity across studies Our assembled effect sizes were more heterogeneous than expected from
chance—even when we allowed that some of this variation could be due to
random noise.
4b. Consider putative moderator variables (optional) We tested for evidence of distinct sub-groups in our dataset, within which the
effects might be more homogeneous. We identified four putative moderators
and codified each study for the following: (i) host taxon; (ii) infection type; (iii)
strain background; and (iv) level of pleiotropy expected, given the particular
mutation(s) involved.
4c. Check for publication bias (optional) We found that smaller/lower-powered studies were more likely to report large
effect sizes in support of the hypothesis, whereas larger/higher-powered
studies tended to report smaller effect sizes.
5. Derive mean effect size(s); quantify influence of moderator
variables (if applicable)
Despite the steps taken (see above), our dataset still showed substantial
heterogeneity. Estimates of mean effect sizes (in/across subgroups) and
moderator coefficients should therefore be viewed as best approximations.
inferred indirectly via genetic analysis); (ii) virulence was
measured in vivo (and not in vitro via virulence factor
production); (iii) virulence was measured quantitatively as direct
damage to the host caused by bacterial infections, and not
by indirect or qualitative measures such as bacterial growth
performance in the host, threshold infective dose required
to kill a host, the damage associated with virulence factor
administration, or resistance to macrophage-like predation
(Ryan et al., 2009; Jeukens et al., 2014; Kirienko et al., 2015);
and (iv) absolute virulence data were presented (and not only
data scaled relative to the wildtype without information on the
absolute risk of mortality, since effect sizes cannot be calculated
from such data). This second set of rules was fulfilled by 24
original publications containing 81 individual experiments (see
Tables S1, S2 in the Supplemental Material). For an overview of
the whole selection process, see Figure S1 in the Supplemental
Material.
Data Extraction and Effect Size
Calculations
From all of these 81 experiments, we extracted information on: (i)
the host organism; (ii) the type of infection; (iii) the observation
period of infected hosts; (iv) the identity of the control (wildtype)
strain; (v) the identity of the pyoverdine-deficient strain; (vi)
the mutated gene in the pyoverdine-defective strain; (vii) the
mutation type (e.g., insertion/deletion); (viii) the sample size used
for the wildtype and mutant experiments; and (ix) the relevant
virulence measure (host survival or tissue damage) for wildtype
and mutant strains (see Table S1 in the Supplemental Material).
This information was used to categorize the experiments and
identify potentially important moderator variables (see below).
Next, we extracted quantitative data from these experiments
so we could calculate effect sizes for the virulence associated with
pyoverdine production. For mortality assays, we extracted raw
counts of howmany individuals (i.e., whole animals or seedlings)
died and how many survived following infection with a dose of
P. aeruginosa wildtype or, alternatively, a mutant strain known to
be deficient for pyoverdine production. For experiments on tissue
damage, we extracted information on the number of individuals
with and without the symptoms related to tissue damage (e.g.,
a lesion in an organ). In cases with zero counts (i.e., either all
or none of the individuals in a particular treatment group died
or experienced tissue damage), we converted counts to 0.5 to
avoid having zero denominators in the subsequent calculations
of the (log-odds ratio) effect sizes (Cox, 1970). In cases where
data from multiple time-points or survival curves were available,
we concentrated on the time point with the largest difference
between the wildtype and the mutant infection.
Using this count data, we calculated the effect
size for each experiment as the log-odds-ratio = ln
((mvirulent/mnon−virulent) /(wvirulent /wnon−virulent)), wheremvirulent
and wvirulent are the number of individuals that died or
experienced tissue damage when infected by the mutant and the
wildtype strain, respectively, and mnon−virulent and wnon−virulent
are the number of individuals that survived or remained
unharmed by the infection. Information on the sample size was
used to calculate the 95% confidence interval for each effect
size and for weighting effect sizes relative to one another (see
details below). Where experiments reported a range of sample
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sizes, we used the arithmetic mean. Some studies reported only
a minimum sample size. In those cases, we used this number.
For experiments using C. elegans, infections were often carried
out on replicate petri dishes in a large number of individuals. In
these cases, we used the total number of individual worms used
in each treatment group as sample size, and not the number of
replica plates.
Additional Analysis: Effect of Pyoverdine
on Growth in Mammalian Hosts
Twelve experiments conducted in mammals that were excluded
from our main meta-analysis contained data on in vivo growth
of wildtype and pyoverdine deficient strains. Ten of these came
from two publications that also supplied virulence measures
meeting our inclusion criteria, while the remaining two came
from studies that did not supply any virulence measures (see
Table S4). While growth is at best an indirect proxy for virulence,
the role of pyoverdine in facilitating in-host growth is an
interesting question to ask when considering the in vivo role
of this molecule. Therefore, we conducted a second, much
smaller meta-analysis of these 12 datasets to investigate whether
pyoverdine production affects P. aeruginosa growth in vivo. We
calculated the standardized mean differences in growth (bacterial
cell counts per gram of tissue or ml of blood) between wild-type
and mutant infections for this set of studies (Table S4, Figure
S2). This secondary dataset shows a similar pattern to the main
meta-analysis shown in Figure 1.
Basic Analytical Approach
Analyses were performed in R version 3.3.1 (R Development
Core Team, 2016), using functions from packages “meta”
(Schwarzer, 2016) and “metaphor” (Viechtbauer, 2010). We used
the “metabin” function to transform the count data into the
(log-) odds ratio described above. We then weighted these values
by the inverse of their respective squared standard errors, and
pooled them to obtain a single distribution of effect sizes. We
reasoned that the variability of the effect sizes in our dataset
probably reflects more than simple sampling error around a
single truemean. Rather, we assume that our effect sizes represent
a random sample from a larger distribution comprising all
possible true effect size estimates. As such, we inferred that a
random effects meta-analysis would be more appropriate for our
dataset than a fixed effects model (for further discussion, see
Borenstein et al., 2009, 2010). In a random effects meta-analysis,
we partition the total heterogeneity observed in our dataset
(described by the statistic Q) into two constituent parts—within-
experiment variation (ε) and between-experiment variation (ζ).
The latter component, scaled appropriately to account for the
weightings intrinsic to meta-analysis, is quantified as the τ2
statistic. There are several different algorithms one can use
to effect this partitioning of variance. We chose a restricted
maximum likelihood (REML) approach. The use of a random
model, rather than a simpler fixed model, affects the weights
accorded to each constituent effect size, which in turn changes
our estimates for pooled means and their associated errors. We
further slightly broadened confidence intervals and weakened
test statistics using Knapp and Hartung’s algorithm (Knapp
and Hartung, 2003)—a widely-used and conservative adjustment
designed to account for the inherent uncertainty associated with
the partitioning of heterogeneity we perform in the course of
fitting a random effects model.
We assessed the degree of residual heterogeneity in our dataset
using statistics I2 andH. I2 estimates the approximate percentage
of total variability across experiments that is attributable to
unexplained heterogeneity, as opposed to simple sampling error
(chance). It is calculated as 100% × (Q–df )/Q, where Q is
Cochrane’s heterogeneity statistic and df its associated degrees
of freedom. H is directly related to I2 (see equation in Higgins
and Thompson, 2002) and reports “excess” heterogeneity as a
fold difference compared to the baseline amount of variability we
would have expected if the sample were homogenous (Higgins
and Thompson, 2002).
Both metrics described above indicated considerable residual
heterogeneity in our dataset, so we inferred that, beyond the
random- and sampling error, some measurable characteristics
of the experiments in our dataset could be contributing, in
predictable ways, to the observed heterogeneity of our assembled
effect sizes. We therefore extended our basic analysis to take
into consideration four potential moderator variables, which we
describe below.
Stratification by Moderator Variables
We selected and defined moderator variables on the basis of (a)
our a priori expectation that they may be important, and (b) the
availability of data. The four we investigated were host taxon,
infection type, the wildtype strain background, and the expected
level of pleiotropy associated with mutations involved. In cases
where information was missing for a specific moderator variable,
we contacted the authors to obtain additional information. For
each moderator, we defined the following relevant subgroups.
Host Organism
Because immune responses and the chemistry of infected
tissue/fluid will vary between host taxa, host taxon could
reasonably be expected to influence both wild-type levels of
virulence and the contribution of siderophores to growth and/or
virulence. We first split experiments into broad taxonomic units
(mammals, invertebrates, plants), and then classified hosts by
genus.
Infection Type
Similarly, different organs or tissue types, even within the same
host, could provide different environments and nutrient regimes
for bacteria. We classified experiments according to the organ or
body region targeted by the infection. Major categories include
infections of the host organisms’ respiratory tract, digestive
system, skin (including burn wounds), and infections that
generated a non-localized infection of the body cavity (systemic
infection). Experiments that did not fit in any of these categories,
such as infections of whole seedlings, were classified as “other
infection types.”
Wildtype Strain Background
Four different P. aeruginosa wildtypes (PAO1, PA14, FRD1, and
PAO6049) were used for infection experiments. These are known
Frontiers in Microbiology | www.frontiersin.org 4 December 2016 | Volume 7 | Article 1952
Granato et al. Meta-Analysis of Pyoverdine’s Effects on Virulence
FIGURE 1 | Forest plots depicting the variation in effect size across experiments on pyoverdine as a virulence factor in P. aeruginosa. All panels display
the same effect sizes originating from the 81 experiments involved in the meta-analysis, but grouped differently according to four moderator variables, which are: (A)
host taxon; (B) infection type; (C) wildtype strain background; and (D) the likelihood of pleiotropy in the pyoverdine-deficient strain. Effect sizes are given as
log-odds-ratio ± 95% confidence interval. Negative and positive effect sizes indicate lower and higher virulence of the pyoverdine-deficient mutant relative to the
wildtype, respectively. The scale of the circular markers is proportional to each experiment’s relative weighting in the context of a (fixed) meta-analysis. As this
weighting is the inverse variance associated with an observed effect, less “noisy” experiments are accorded larger weights. Diamonds represent the mean effect sizes
(obtained from meta-regression analysis) for each subgroup of a specific moderator variable. IDs of the individual experiments are listed on the Y-axis (for details, see
Table S1 in the Supplemental Material). The numbers in brackets on the Y-axis correspond to the citation number of the corresponding publication.
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to differ from one another genetically and phenotypically: for
instance, PA14 is generally found to be more virulent than
PAO1 across a range of lab models. As background genotype
and virulence levels might affect the impact of siderophore
mutation on virulence, we included wild-type strain in our
analysis. Although it is well established that even standard strains
such as PAO1 can substantially differ between labs, there was not
enough information available to take such strain-level variation
into account.
Likelihood of Pleiotropy
The focal phenotype investigated in this meta-analysis is the
production of pyoverdine, the main siderophore of P. aeruginosa.
Mutants exhibiting reduced or no pyoverdine production can be
generated either by deleting a specific pyoverdine-synthesis gene,
or through untargeted mutagenesis (e.g., UV light, Hohnadel
et al., 1986). The latter mutants are likely to have mutations in
other genes unrelated to pyoverdine synthesis. These mutations
are typically unknown but could also affect virulence. In
principle, even single gene deletions can have pleiotropic effects
on the phenotype, via disruption of interactions with other
genes. Depending on the locus in question, certain genetic
modifications are more likely to have pleiotropy—and so affect
the expression of other virulence factors—than others. To
account for these complications, we inferred on a case-by-case
basis whether the mutation used was likely to only induce a
change in (or loss of) pyoverdine production (i.e., pleiotropy
less likely) or was likely to induce a change in other phenotypes
as well (i.e., pleiotropy more likely). In the biosynthesis of
pyoverdine, multiple enzymes are involved in non-ribosomal
peptide synthesis (Visca et al., 2007). Two gene clusters, the
pvc operon and the pvd locus, encode proteins involved in the
synthesis of the chromophore and peptide moieties, respectively
(Stintzi et al., 1999; Visca et al., 2007). In most of these genes,
a mutation or deletion leads to a complete loss of pyoverdine
production, and most likely does not affect any other trait.
Accordingly, we assigned mutants carrying mutations in these
genes to the category “pleiotropy less likely.” An exception
is pvdQ, a gene coding for a periplasmic hydrolase, which is
required for pyoverdine production, but is also involved in
the degradation of N-acyl-homoserine lactone quorum-sensing
molecules (Nadal Jimenez et al., 2010). Strains with deletions
in this gene were therefore assigned to the category “pleiotropy
more likely.” Other strains falling into this category included:
(i) mutants where the key regulator of pyoverdine synthesis,
PvdS, was deleted, leading to deficiencies in toxin and protease
production, in addition to a complete loss of pyoverdine
production (Beare et al., 2003); (ii) strains that carry a deletion
in a central metabolic gene and only coincidentally show no (or
strongly reduced) pyoverdine production; (iii) double mutants
that carry deletions in both the pyoverdine and the pyochelin
synthesis pathway (pyochelin is the secondary siderophore of
P. aeruginosa, Braud et al., 2009); and (iv) pyoverdine mutants
created via non-targeted (e.g., UV) mutagenesis.
Using the stratification described above, we focused on
estimating mean effect sizes and their associated confidence
intervals within all subgroups represented in our full dataset (i.e.,
the diamonds in Figure 1). To this end, we fitted a series of four
univariate models, one for each moderator. Each model was a
random-effects meta-analysis (as above) but we constrained the
level of between-experiment heterogeneity (τ2) to be common
across all subgroups (i.e., each factor level of themoderator under
examination).
Comparison of Moderator Variables’
Relative Influence
To better understand the relative importance of the four
moderator variables described above, we focused on a reduced
“core” dataset, for which we excluded experiments belonging to
rare or poorly characterized subgroups to generate a smaller but
more homogenous dataset. We excluded experiments involving
plants and/or undefined wildtype strains (n = 6), experiments
reporting tissue damage as a measure of virulence (n = 12), and
experiments where the hosts were likely not colonized by bacteria
but died from exposure to bacterial toxins (n = 8). This resulted
in a core dataset comprising 55 experiments.
Using this dataset, we then fitted meta-regression models
that simultaneously considered the contributions of multiple
moderator factors. Our models were able to estimate moderators’
additive effects only, because even in this “core” dataset, with
its comparatively better data coverage across the remaining
subgroups, the distribution of data across different combinations
of factor levels was still too patchy to permit a proper
investigation of moderators’ interactive effects. Moderators’
alterations of the expected (i.e., baseline) effect size could be
quantified as coefficients, which could, when standardized as
t-statistics, be tested for significant differences from zero. In
addition, we could test whether, collectively, the inclusion of
moderators in our meta-analysis model significantly reduced the
residual heterogeneity relative to a situation with no moderators.
To estimate what share of the residual heterogeneity in
our dataset could be individually attributable to each of the
respective moderators, we performed a series of likelihood ratio
tests comparing, in each case, a full model including all four
moderators, against a reduced model that excluded one of the
moderators. Variance component estimation in these models
used maximum likelihood instead of REML because nested
REML models cannot be compared in this way. From each
pairwise comparison, we obtained a pseudo-R2 value, which
reflects the difference in τ2 (between-experiment heterogeneity)
between the two models, scaled by the τ2 of the simpler model.
Potential Within-Study Bias
The most likely source of potential directional bias within
studies is the genotype of the siderophore mutant used. One
unpublished dataset was excluded partly because the siderophore
mutant used carried a mutation in a locus that is not essential
for siderophore production (Table S3), and so experiments
using this mutant may be biased toward finding no effect of
mutation on virulence. Sixteen included datasets used pvdS
mutants; because pvdS positively regulates the expression of other
virulence factors as well as siderophores, experiments using this
mutant may be biased toward finding an effect of mutation on
virulence. Similarly, three included datasets used a UV-generated
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mutant, PAO6609 (PAO9) which carries mutations in several loci
affecting growth or virulence (F. Harrison, A. McNally, A. Da
Silva & S. P. Diggle, unpublished data). Because we included
likelihood of pleiotropy as a moderator variable in our analysis,
we should be able to partition out between-study variance caused
by the use of mutants that risk a bias toward positive results.
Testing for Signs of Publication Bias
To test for putative publication bias in our dataset, we compared
effect sizes against their respective standard errors, the idea
being that if there is no bias, there should be no link between
the magnitude of the result from a given experiment, and
the “noisiness” or uncertainty of that particular result. If
there is bias, we could find an overrepresentation of noisier
experiments reporting higher magnitude results. Using the
“metabias” function of the R package “meta,” we performed both
(weighted) linear regressions and rank correlations to test for this
pattern (Begg and Mazumdar, 1994; Egger et al., 1997).
RESULTS
Literature Search and Study
Characteristics
We searched the literature for papers featuring infections
of whole live host organisms with P. aeruginosa strains
known to vary in pyoverdine phenotype. Following a set
of inclusion/exclusion rules (see materials and methods for
details), we were able to include data from a total of 81
experiments from 24 original papers in our meta-analysis
(Table 1; see also Figure S1 and Tables S1, S2 in the Supplemental
Material). These experiments featured a range of host organisms,
including mammals (mice and rabbits, n = 37), the nematode
Caenorhabditis elegans (n = 32), insects (fruit fly, silk worm
and wax worm, n = 8) and plants (wheat and alfalfa,
n = 4). Experiments further differed in the way infections
were established and in the organs targeted. The most common
infection types were gut (n = 34), systemic (n = 16), respiratory
(n = 13) and skin infections (n = 6), but we also included some
other types of infections (n = 12). Each experiment compared
infections with a control P. aeruginosa strain (which produced
wildtype levels of pyoverdine) to infections with a mutant
strain defective for pyoverdine production. The most common
control strains used were PAO1 (n = 58) and PA14 (n = 19),
which are both well-characterized clinical isolates. However,
some experiments used less well-characterized wildtype strains,
such as FRD1 (n = 2) and PAO6049 (n = 2). Twenty-
eight experiments used mutant strains with clean deletions or
transposon Tn5 insertions in genes encoding the pyoverdine
biosynthesis pathway. In these cases, pleiotropic effects are
expected to be relatively low—i.e., presumably only pyoverdine
production was affected. The other 53 experiments used mutants
where pleiotropic effects were likely or even certain. For
example, some mutant strains carried mutations in pvdS, which
encodes the main regulator of pyoverdine synthesis that also
regulates the production of toxins and proteases (Ochsner et al.,
1996; Wilderman et al., 2001). Others carried mutations in
pvdQ, encoding an enzyme known to degrade quorum-sensing
molecules in addition to its role in pyoverdine biosynthesis
(Nadal Jimenez et al., 2010).
Mean Effects across and Within Subgroups
We combined data from the set of experiments described above
in a meta-analysis to determine the extent to which pyoverdine’s
effect on virulence varied across fourmoderator variables: (i) host
taxa, (ii) tissue types, (iii) pathogen wildtype background, and
(iv) pyoverdine-mutation type. To obtain a comparable measure
of virulence across experiments, we extracted in each instance
the number of cases where a given infection type did or did
not have a virulent outcome (i.e., dead vs. alive, or with vs.
without symptoms) for both the mutant (m) and the wildtype
(w) strain for each experiment (see materials and methods for
details). We then took as our effect size the log-odds-ratio,
i.e., ln((mvirulent/mnon−virulent)/(wvirulent/wnon−virulent)) (see Table
S2 in the Supplemental Material), a commonly-used measure
especially suitable for binary response variables like survival
(Szumilas, 2010).
Consistent with the theoretical prediction that host-pathogen
interactions and host ecology are important modulators of
virulence, we found considerable variation in the effect
sizes across experiments and subgroups of all moderators
(Figure 1). Pyoverdine-deficient mutants showed substantially
reduced virulence in invertebrate and mammalian hosts,
whereas there was little evidence for such an effect in
plants (Figure 1A). Overall, evidence for pyoverdine being
an important virulence factor was weak for taxa with a
low number of experiments (i.e., for plants, and the insect
models Drosophila melanogaster and Galleria mellonella). We
found that pyoverdine-deficient mutants exhibited reduced
virulence in all organs and tissues tested, with the exception of
plants (Figure 1B). Comparing the effect sizes across wildtype
strain backgrounds, we see that pyoverdine deficiency reduced
virulence in experiments featuring the well-characterized PA14
and PAO1 strains (Figure 1C) whereas the reduction was less
pronounced in experiments with less well-characterized wildtype
strains. This could be due to sampling error (only a few
experiments used these strains) or it may be that these strains
really behave differently from PA14 and PAO1. Finally, we
observed that the nature of the pyoverdine-deficiency mutation
matters (Figure 1D). Infections with strains carrying well-
defined mutations known to exclusively (or at least primarily)
affect pyoverdine production showed a relatively consistent
reduction in virulence. Conversely, where mutants were poorly-
defined, or carried mutations likely to affect other traits
beyond pyoverdine, here the virulence pattern was much more
variable, with both reduced and increased virulence relative to
wildtype infections (Figure 1D). We posit that at least some
of the differences in observed virulence between these mutants
and their wildtype counterparts was likely due to pleiotropic
differences in phenotypes unrelated to pyoverdine.
Relative Importance of Moderator
Variables
Figure 1 highlights that we are dealing with an extremely
heterogeneous dataset (a randommeta-analysis of the full dataset
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without moderators yielded heterogeneity measures I2 = 97.92%
(97.16–98.48) andH = 6.93 (5.93–8.10), where values in brackets
indicate the 95% confidence limits associated with each estimate).
Much of the variation we observe is probably due to other factors
beyond those explored in Figure 1. The issue is that (a) we
do not know what all these additional factors might be, and
(b) the probably patchy distribution of experiments across the
levels and ranges of these other factors would leave us with
limited power to test for their effects. Accordingly, we decided
to focus our attention on quantifying the impact of the four
previously described moderators by using a more homogenous
core dataset (n = 55), where rare and poorly characterized
subgroups were removed. Specifically, we excluded experiments
involving plants and/or undefined wildtype strains (n = 6),
experiments reporting tissue damage as a measure of virulence
(n= 12), and experiments where the hosts were likely not directly
colonized by bacteria but died from exposure to bacterial toxins
(n = 8). This leaves us with a core dataset comprising only
those experiments where animal host models were infected with
strains from well-defined PA14 or PA01 wildtype background,
and survival vs. death was used as a virulence endpoint.
Using this restricted dataset, we performed a series of meta-
regression models to test for significant differences between
subgroups of our moderator factors, and we also estimated
the share of total variance in effect sizes that is explained by
each moderator variable (Figure 2). These models revealed that
infection type is the variable that explains the largest share of total
variance (25.4%). For instance, in systemic infection models the
pyoverdine-defectivemutants showed strongly reduced virulence
compared to the wild-type, whereas this difference was less
pronounced in gut infections. Host taxon explained only 8.2%
of the total variance in effect sizes, and there was no apparent
difference in the mean effect size among invertebrate vs.
mammalian host models. Finally, the wildtype strain background
and the likelihood of pleiotropy in the mutant strain both
explained less than 1% of the overall effect size variation,
and accordingly, there were no apparent differences between
subgroups (Figure 2). This was interesting, because we predicted
a priori that mutations with pleiotropic effects on other virulence
factors could introduce within-study bias toward a greater effect
of siderophore loss on virulence. Note that even with the
inclusion of these moderator factors in the model, substantial
heterogeneity remained in our restricted data set [I2 = 96.15%
(94.23–97.43), H = 5.10 (4.16–6.24)].
Publication Bias
In any field, there is a risk that studies with negative or
unanticipated results may be less likely to get published (e.g.,
in our case, pyoverdine-deficient mutants showing no change or
increased levels of virulence, Dwan et al., 2008). Especially when
negative or unanticipated results are obtained from experiments
featuring low sample sizes (and thus high uncertainty), the
scientists responsible may be less inclined to trust their results,
and consequently opt not to publish them. This pattern could
result in a publication bias, and an overestimation of the effect
size. To test whether such a publication bias exists in our dataset,
we plotted the effect size of each experiment against its (inverted)
standard error (Figure 3). If there is no publication bias, we
would expect to see an inverted funnel, with effect sizes more or
less evenly distributed around the mean effect size, irrespective
of the uncertainty associated with each estimate (i.e., position
on the y-axis). Instead, we observed a bias in our dataset, with
many lower-certainty experiments that show strongly negative
effect sizes (i.e., supporting the hypothesis that pyoverdine is
important for virulence; Figure 3) but a concomitant paucity of
lower-certainty experiments that show weakly negative, zero or
positive effect sizes (i.e., not supporting the hypothesis).
DISCUSSION
What Have We Learned from this
Meta-Analysis
Ourmeta-analysis reveals that pyoverdine-deficient strains of the
opportunistic pathogen P. aeruginosa typically showed reduced
virulence across a wide range of host species and bacterial
genotypes. This confirms that iron limitation is a unifying
characteristic of the host environment, making siderophores an
important factor for pathogen establishment and growth within
the host (Parrow et al., 2013; Becker and Skaar, 2014). However,
we also saw that the extent to which pyoverdine deficiency
reduced virulence varied considerably, and was quite modest
in many instances. Pyoverdine-deficient mutant strains were
typically more benign, owing to a reduced capacity for in vivo
growth and/or a reduced capacity for inflicting damage on their
host. Nonetheless, these mutants were typically still able to
establish a successful infection, and, in many cases, could still kill
their host (Romanowski et al., 2011; Kirienko et al., 2013; Ross-
Gillespie et al., 2014; Lopez-Medina et al., 2015). These results
support ecological theory predicting that the effect of a certain
phenotype (i.e., producing pyoverdine in our case) should vary in
response to the environment (i.e., the host and infection context,
Lambrechts et al., 2006).
Our findings have direct consequences for any therapeutic
approaches targeting this particular virulence factor. Because
pyoverdine seems to be generally involved with virulence,
treatments inhibiting pyoverdine production could have wide
applicability and be effective against different types of infections
across a wide host range. However, given the variation observed
and pyoverdine’s generally modest effect on virulence, the clinical
impact of such treatments would likely vary across infection
contexts, and be limited to attenuating rather than curing the
infection. This would mean that for P. aeruginosa infections, at
least, therapies targeting siderophore production could be helpful
but should probably still be accompanied by other therapeutic
measures, and applied for instance in combination with an
antibiotic treatment (Banin et al., 2008). Certainly promising is
that pyoverdine seems to have a more consistent (Figure 1A)
and more prominent (Figure 2 although not significant) effect
in mammalian compared to invertebrate hosts. From this
observation, one could infer that pyoverdine may have potential
as a target for infection control in humans.
Our work demonstrates how meta-analyses can be used
to quantitatively synthesize data from different experiments
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FIGURE 2 | Test for differences between subgroups of moderator variables with regard to the effect sizes for pyoverdine as a virulence factor in
P. aeruginosa. Our baseline condition for all comparisons is the following: gut infections in invertebrate hosts, using the P. aeruginosa wildtype strain PA14 vs. a
pyoverdine-deficient PA14 mutant with a low expected level of pleiotropy. The effect size for this baseline scenario is set to zero. All other scenarios had more extreme
(negative) effect sizes, and are therefore scaled relative to this baseline condition. Comparisons reveal that virulence in pyoverdine-deficient strains was significantly
more reduced in systemic compared to gut infections, and that most effect size variation is explained by the infection type. There were no significant effect size
differences between any of the other subgroups. Bars show the difference in log odds-ratio (± 95% confidence interval) between the baseline and any of the alternate
conditions. Values given in brackets indicate percentage of effect size heterogeneity explained by a specific moderator.
carried out at different times by different researchers using
different designs. Such an analytical approach goes beyond a
classical review, where patterns are typically summarized in a
qualitative manner. For instance, a recent study proposed that
three different virulence factors (pyocyanin, protease, swarming)
of P. aeruginosa are host-specific in their effects (Dubern et al.,
2015). Here we use a meta-analytic approach to quantitatively
derive estimates of the overall virulence potential of a given
bacterial trait and investigate variables that affect infection
outcomes. We assert that such quantitative comparisons are
essential to identify those virulence factors that hold greatest
promise as targets for effective broad-spectrum anti-virulence
therapies.
Our finding that effect sizes vary considerably across
our assembled experiments provides a different perspective
compared to that which one would obtain from a cursory
reading of the literature. For instance, the first study investigating
pyoverdine in the context of an experimental infection model
(Meyer et al., 1996) reported that pyoverdine is essential for
virulence. Although this experiment and its message have
been widely cited (including by ourselves), it may no longer
be the strongest representative of the accumulated body of
research on this topic. As we see in Figure 1, the effect size
it reports is associated with a high uncertainty due to a
comparatively low sample size. Moreover, the observed effect
cannot unambiguously be attributed to pyoverdine because an
undefined UV-mutagenized mutant was used. We highlight
this example not to criticize it, but rather because it serves
to demonstrate why drawing inferences from (appropriately
weighted) aggregations of all available evidence is preferable to
focusing solely on the results of a single study.
Areas of Concern
Our meta-analytic approach not only provides information
on the overall importance of pyoverdine for P. aeruginosa
virulence, but it also allows us to identify specific gaps in
our knowledge. For example, let us consider which types of
studies were conspicuously absent from our dataset. First, most
experiments in our dataset employed acute infection models,
even though P. aeruginosa is well known for its persistent, hard-
to-treat chronic infections. This raises the question to what
extent insights on the roles of virulence factors important in
acute infections can be transferred to chronic infections. In
the case of pyoverdine, we know that in chronically-infected
cystic fibrosis airways, pyoverdine production is often selected
against (Wiehlmann et al., 2007; Jiricny et al., 2014; Andersen
et al., 2015). Although the selective pressure driving this
evolutionary loss is still under debate (current explanations
include pyoverdine disuse, competitive strain interactions and/or
a switch to alternative iron-uptake systems, Marvig et al., 2014;
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FIGURE 3 | Association between effect sizes and their standard errors
across 81 experiments examining the role of pyoverdine production for
virulence in P. aeruginosa. In the absence of bias, we should see an
inverted funnel-shaped cloud of points, more or less symmetrically distributed
around the mean effect size (vertical dotted line). Instead, we see an
over-representation of low-certainty experiments associated with strong
(negative) effect sizes. This suggests a significant publication bias: experiments
with low-certainty and weak or contrary effects presumably do exist, but are
under-represented here (note the absence of data points in the cross-hatched
triangle). Effect sizes are given as log-odds-ratio. Each symbol represents a
single experiment. Symbol colors and shapes stand for different host
organisms (red circles, invertebrates; blue squares, mammals; green
diamonds, plants). Large symbols denote the experiments included in the core
dataset. The solid shaded area represents the 95% confidence interval for the
weighted linear regression using the complete dataset. Note that due to the
stronger weights accorded to high certainty experiments (i.e., the points
toward the top of the plot), many of the lower-weighted (higher-uncertainty)
points toward the bottom of the plot lie quite far from the regression line and
also outside the confidence interval.
Andersen et al., 2015; Kümmerli, 2015), this example illustrates
that the role of pyoverdine might differ in acute vs. chronic
infections.
Second, our comparative work shows that experiments were
predominantly carried out with the well-characterized strains
PAO1 and PA14. While these strains were initially isolated from
clinical settings, they have subsequently undergone evolution in
the laboratory environment (Bragonzi et al., 2009; Klockgether
et al., 2011; Frydenlund Michelsen et al., 2015), and might now
substantially differ from the clinical strains actually causing acute
infections in hospitals. Therefore, while we found no overall
differences between the lab strains used in our data set, we argue
that it would still be useful to carry out additional studies on a
range of clinical isolates to be able to make firm conclusions on
the general role of pyoverdine as a virulence factor.
Finally, our data analysis revealed that low-certainty studies
showing no or small effects of pyoverdine on virulence were
under-represented in our data set, which points toward a
systematic publication bias. It remains to be seen whether such
biases are common with regard to research on virulence factors,
and whether they result in a general overestimation of the effect
these factors have on host survival or tissue damage. With regard
to pyoverdine, further studies are clearly needed to obtain a more
accurate estimate of the true effect size.
In addition to these issues of data availability, all meta-
analyses unavoidably involve intrinsic assumptions and
subjective decisions that can further influence the resulting
outputs. For instance, although we have used the standard
log-odds-ratio as our common metric, related metrics like
risk ratios, while typically highly correlated, can sometimes
produce different patterns in a meta-analysis. In the present case,
however, using risk ratios instead does not qualitatively affect the
patterns we observed nor alter our conclusions. Furthermore,
to facilitate calculation of a log-odds ratio in cases where zero
counts appear as denominators, we have in this study adopted
the common, yet ultimately arbitrary, convention of replacing
these zero denominators with 0.5. Had we used a different value
as a substitute, say 0.1 or 0.9, the estimates from our resulting
models would have been different—at least quantitatively. A
more fundamental issue is that when estimating population-level
statistics across a collection of experiments, we typically assume
that we are comparing like with like. Here, we have intentionally
brought together a very diverse set of studies, and even though
we have translated their individual effect sizes into a common
metric and also stratified them by some of their major defining
characteristics, their individual effect sizes nonetheless remain
highly heterogeneous. In effect, we are knowingly combining
apples and pears, because we think that the resulting fruit salad
is still something that is worth taking a look at. Alternative or
additional ways of slicing up the data could yield models with
lower residual heterogeneity, but then poor data coverage in
combinations of subcategories could limit the accuracy of any
parameter estimates we want to extract from such models. In
light of these issues, we advise readers to focus on the overall
patterns our models reveal, rather than the specific values of the
estimates they generate.
Guidelines for Future Studies
While our study demonstrates the strength of quantitative
comparative approaches, it is important to realize that extracting
effect sizes is one of the biggest challenges in any meta-analysis.
This challenge was particularly evident for the experiments we
found, which profoundly varied in the way data was collected
and reported. As a consequence, we had to exclude many studies
because they used measures of virulence that were only reported
by a minority of studies, or because their reporting of results
was unclear (for a selected list of examples, see Table S3 in the
Supplemental Material). To amend this issue for future studies,
we would like to first highlight the problems we encountered and
then provide general guidelines of how data reporting could be
improved and standardized. One main problem we experienced
was incomplete data reporting (i.e., mean treatment values,
absolute values and/or sample size was not reported), which
prevents the calculation of effect sizes and uncertainty measures.
Another important issue was that different studies measured
virulence using very different metrics. Some measured virulence
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at the tissue level (i.e., the extent of damage inflicted), while
others focused on the whole host organism. Others focused on
the dynamics of the bacteria themselves, taking this as a proxy
for the eventual damage to the host. There were both quantitative
measures (e.g., extent of damage), and qualitative measures (e.g.,
assignments to arbitrary categories of virulence). Survival data
was sometimes presented as a timecourse, sometimes as an
endpoint; sometimes as raw counts, sometimes as proportions. In
most cases, the time scales over which survival was assessed were
fairly arbitrary. Compiling such diverse measures of virulence is
not simply time consuming, but it also generates extra sources of
heterogeneity in the dataset, which might interfere with the basic
assumptions of meta-analytical models (Borenstein et al., 2009,
2010).
How can these problems be prevented in future studies? We
propose the following. (a) Whenever possible, time-to-event data
(e.g., death, organ failure, etc.) should be recorded in a form
that preserves both the outcome and the times to event per
subject. (b) The number of replicates used (hosts) and a measure
of variance among replicates must be provided to be able to
calculate a confidence estimate for the experiment. (c) If data
are scaled in some way (e.g., relative to a reference strain), the
absolute values should still be reported, because these are crucial
for the calculation of effect sizes. Finally, (d) studies leading to
unexpected or negative results (e.g., no difference in virulence
between a wildtype and a mutant) should still be published, as
they are needed to estimate a true and unbiased effect size. In
summary, all findings, irrespective of their magnitude or polarity,
should be presented “as raw as possible” (e.g., in Supplementary
files or deposited in online data archives). This will make
comparisons across studies much easier and will provide a useful
resource for future meta-analytic studies.
CONCLUSIONS
Currently, bacterial traits are subject to a binary categorisation
whereby some are labeled as virulence factors while others
are not. We demonstrate that traits’ effects on virulence are
anything but binary. Rather, they strongly depend on the
infection context. Our study affirms meta-analysis as a powerful
tool to quantitatively estimate the overall effect of a specific
virulence factor and to compare its general importance in
infections across different bacterial strains, hosts, and host
organs. Such quantitative comparisons provide us with a more
complete picture on the relative importance of specific virulence
factors. Such knowledge is especially valuable for opportunistic
pathogens, which have a wide range of virulence factors at their
disposal, and infect a broad range of host organisms (Kurz et al.,
2003; He et al., 2004; Calderone and Fonzi, 2001).Meta-analytical
comparisons could thus inform us on which traits would be best
suited as targets for anti-virulence therapies. Ideal traits would
be those with high effect sizes and general importance across
pathogen and host organisms.
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